Located in SIDCO Industrial Area, Samba (Jammu & Kashmir), this compact yet highly efficient manufacturing unit spans 24 kanal. and is designed to deliver quality-driven pharmaceutical products with speed and precision.

The facility is equipped to manufacture tablets, capsules, dry syrups, and ointment tubes, making it a versatile contributor to our ethical and contract manufacturing business segments.

Built as per current Good Manufacturing Practices (cGMP), the unit integrates modern machinery and strong quality assurance systems to meet national and international compliance standards.

Its strategic location supports seamless logistics and distribution across key markets. With its focused capacity and compliance-driven processes, the Samba unit stands as a vital part of Ind-Swift’s manufacturing ecosystem — committed to delivering safe, affordable, and effective healthcare solutions.

Own Marketing Setup

Strong presence in domestic and international markets through our in-house marketing and sales teams across various therapeutic segments.

Our operations are driven by automation, lean practices, and a continuous improvement mindset, allowing us to deliver consistent quality with speed and efficiency.

At Ind-Swift Group, our diversified business model is designed to create long-term value through multiple engagement avenues across the pharmaceutical value chain. We collaborate with partners worldwide through flexible and growth-driven approaches.

Dossier Out-Licensing

Offering high-quality, CTD-compliant dossiers for out-licensing in regulated and semi-regulated markets, enabling partners to register and commercialize products efficiently.

Contract Research &
Contract Development

End-to-end support from formulation development to scale-up, regulatory documentation, and clinical support — all under strict quality and confidentiality norms.